Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
1,029 adverse event reports (+47% vs 2021)
In 2022, 1,029 adverse event reports were filed for Influenza, Seasonal (Flucelvax Quadrivalent) in VAERS. This represents 11.6% of all 8,852 reports for this vaccine.
Of these reports, 7 mentioned death, 32 involved hospitalization, 132 required ER visits, and 14 reported disability.
Compared to the average of 860 reports per year for this vaccine, 2022 was above average (+20%).
In 2022, reporting for Influenza, Seasonal (Flucelvax Quadrivalent) was within typical ranges. As always, VAERS data reflects reports filed, not confirmed adverse events. Trends should be interpreted alongside vaccination volume and population health data.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.